4//SEC Filing
McGroarty Jeffrey Brian 4
Accession 0001104659-21-147676
CIK 0001477845other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:01 PM ET
Size
7.8 KB
Accession
0001104659-21-147676
Insider Transaction Report
Form 4
McGroarty Jeffrey B
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2021-12-06+165,199→ 165,199 totalExercise: $20.97Exp: 2031-12-06→ Common Stock (165,199 underlying) - Award
Stock Option (right to buy)
2021-12-06+30,396→ 30,396 totalExercise: $20.97From: 2021-12-06Exp: 2031-12-06→ Common Stock (30,396 underlying)
Footnotes (2)
- [F1]The stock option is 100% vested.
- [F2]The stock option shall vest in two installments: (i) the first installment of 82,600 shares on March 31, 2022 and (ii) a second and final installment of 82,599 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date.
Documents
Issuer
Annovis Bio, Inc.
CIK 0001477845
Entity typeother
Related Parties
1- filerCIK 0001563273
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 5:01 PM ET
- Size
- 7.8 KB